Prednisone and Fulvestrant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prednisone (prednisone) and Fulvestrant (fulvestrant). Common drug interactions include diarrhoea among females.

The phase IV clinical study analyzes what interactions people have when they take Prednisone and Fulvestrant. It is created by eHealthMe based on reports of 95 people who take the same drugs from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

What is Fulvestrant?

Fulvestrant has active ingredients of fulvestrant. eHealthMe is studying from 15,769 Fulvestrant users. Check the latest studies of Fulvestrant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

95 people who take Prednisone and Fulvestrant together, and have interactions are studied.

Prednisone and Fulvestrant drug interactions.

What are the common drug interactions of Prednisone and Fulvestrant, by gender? *:

female:

Diarrhoea
Nausea (feeling of having an urge to vomit)
Hyperhidrosis (abnormally increased sweating)
Drug ineffective
Neoplasm progression (growth of tumour)
Arthralgia (joint pain)
Breast cancer female
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Myocarditis (inflammation of heart muscle myocardium)
Pain

male:

n/a

What are the common drug interactions of Prednisone and Fulvestrant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Breast cancer metastatic
Asthenia (weakness)
Cardiospasm (heart spasm)
Disease progression
Dizziness
Drug ineffective
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Pain
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)

50-59:

Lymphadenopathy (disease or enlargement of lymph nodes)
Pyrexia (fever)
Rash
Alanine aminotransferase increased
Arthralgia (joint pain)
Aspartate aminotransferase increased
Dizziness
Drug ineffective
Gait disturbance
Hypertension (high blood pressure)

60+:

Diarrhoea
Nausea (feeling of having an urge to vomit)
Pneumonia
Malaise (a feeling of general discomfort or uneasiness)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Myocarditis (inflammation of heart muscle myocardium)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Arthralgia (joint pain)
Neutropenia (an abnormally low number of neutrophils)
Cough

What are the existing conditions these people have? *

Breast Cancer Metastatic: 29 people, 30.53%
Breast Cancer: 17 people, 17.89%
Breast Cancer Female: 10 people, 10.53%
Pain: 9 people, 9.47%
High Blood Pressure: 9 people, 9.47%
Nausea (feeling of having an urge to vomit): 6 people, 6.32%
Depression: 6 people, 6.32%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 6.32%
Hypersensitivity: 5 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and Fulvestrant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously